Note 8 - Segment Information and Disaggregated Revenue

3 Months Ended

Sep. 30, 2020

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note

8.

Segment Information

and Disaggregated Revenue

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company's operating segments.

The Company has divided its operations into

two

reportable segments as follows: Contract Manufacturing, and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the

three

months ended

September 30, 2020

and

2019

were

$1,467

and

$2,026,

respectively.

Financial information relating to the

three

months ended

September 30, 2020

and

2019

operations by business segment and disaggregated revenues was as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit (Loss)		Depreciation		Expenditures
Contract Manufacturing	2020	$	13,324	$	1,462	$	14,786	$	2,255	$	82	$	50
	2019		9,001		1,983		10,984		1,250		90		58
Other Nutraceutical Businesses	2020		381		5		386		118		1		3
	2019		379		43		422		149		1		-
Total Company	2020		13,705		1,467		15,172		2,373		83		53
	2019		9,380		2,026		11,406		1,399		91		58

	Total Assets as of
	September 30,		June 30,
	2020		2020
Contract Manufacturing	$	21,429	$	19,581
Other Nutraceutical Businesses		3,201		3,363
Total Company	$	24,630	$	22,944